Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Li-Fraumeni & TP53: Understanding and Progress (LiFT UP)

NCT04541654 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT04541654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Li-Fraumeni & TP53: Understanding and Progress (LiFT UP)
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2020
Completion date
December 31, 2032
Enrollment
1,500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clonal hematopoiesis, hereditary cancer syndrome, li-fraumeni syndrome, mosaicism, tp53 gene mutation